Association of serum eicosapentaenoic acid to arachidonic acid ratio with microalbuminuria in a population of community-dwelling Japanese

Atherosclerosis

Volumn 239, Issue 2, 2015, Pages 577-582

  Fukami, Ako ^a   Adachi, Hisashi ^a   Hirai, Yuji ^a   Enomoto, Mika ^a   Otsuka, Maki ^a   Kumagai, Eita ^a   Nakamura, Sachiko ^a   Yoshimura, Ayako ^a   Obuchi, Aya ^a   Nohara, Yume ^a   Nakao, Erika ^a   Hori, Kensuke ^a   Fukumoto, Yoshihiro ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AA; EPA; EPA AA ratio; Epidemiology; Microalbuminuria

Indexed keywords

ALBUMIN; ARACHIDONIC ACID; C REACTIVE PROTEIN; CREATININE; HEMOGLOBIN A1C; ICOSAPENTAENOIC ACID; BIOLOGICAL MARKER;

AGED; ARTICLE; BLOOD ANALYSIS; CITY; CREATININE URINE LEVEL; DISEASE ASSOCIATION; DRINKING BEHAVIOR; EICOSAPENTAENOIC ACID TO ARACHIDONIC ACID RATIO; FATTY ACID BLOOD LEVEL; FEEDING BEHAVIOR; FEMALE; HUMAN; JAPAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NUTRITIONAL PARAMETERS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUESTIONNAIRE; SYSTOLIC BLOOD PRESSURE; URINALYSIS; ALBUMINURIA; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; DIET; EPIDEMIOLOGY; ETHNOLOGY; INDEPENDENT LIVING; MIDDLE AGED; PREVALENCE; RISK FACTOR; URINE;

AGED; ALBUMINURIA; ARACHIDONIC ACID; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS; CREATININE; DIET; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; INDEPENDENT LIVING; JAPAN; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 84923324364     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.02.033     Document Type: Article

References (42)

1. Kromhout D., Bosschieter E.B., de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N.Engl. J. Med. 1985, 312:1205-1209.
2. Daviglus M.L., Stamler J., Orencia A.J., et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N.Engl. J. Med. 1997, 336:1046-1053.
3. Albert C.M., Campos H., Stampfer M.J., et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N.Engl. J. Med. 2002, 346:1113-1118.
4. Hu F.B., Bronner L., Willett W.C., et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002, 287:1815-1821.
5. Iso H., Kobayashi M., Ishihara J., et al. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 2006, 113:195-202.
6. Yokoyama M., Origasa H., Matsuzaki M., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369:1090-1098.
7. Itakura H., Yokoyama M., Matsuzaki M., et al. Relationships between plasma fatty acid composition and coronary artery disease. J.Atheroscler. Thromb. 2011, 18:99-107.
8. Yudkin J.S., Forrest R.D., Jackson C.A. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 1988, 2:530-533.
9. Hillege H.L., Fidler V., Diercks G.F., et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002, 106:1777-1782.
10. Yuyun M.F., Khaw K.T., Luben R., et al. Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. Int. J. Epidemiol. 2004, 33:189-198.
11. Stehouwer C.D., Smulders Y.M. Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J.Am. Soc. Nephrol. 2006, 17:2106-2111.
12. Sasaki S., Ushio F., Amano K., et al. Serum biomarker-based validation of a self-administered diet history questionnaire for Japanese subjects. J.Nutr. Sci. Vitaminol. Tokyo 2000, 46:285-296.
13. Matsuzaki M., Yokoyama M., Saito Y., et al. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease. Circ. J. 2009, 73:1283-1290.
14. Takemoto Y., Suzuki Y., Horibe R., et al. Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders. Brain Dev. 2003, 25:481-487.
15. Ninomiya T., Nagata M., Hata J., et al. Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: the Hisayama Study. Atherosclerosis 2013, 231:261-267.
16. Kumagae S., Adachi H., Jacobs D.R., et al. High level of plasma endothelin-1 predicts development of hypertension in normotensive subjects. Am. J. Hypertens. 2010, 23:1103-1107.
17. Tsukagawa E., Adachi H., Hirai Y., et al. Independent association of elevated serum hepatocyte growth factor levels with development of insulin resistance in a 10-year prospective study. Clin. Endocrinol. Oxf. 2013, 79:43-48.
18. Otsuka M., Adachi H., Jacobs D.R., et al. Serum hepatocyte growth factor and cancer mortality in an apparently healthy Japanese population. J.Epidemiol. 2012.
19. Kumagai E., Adachi H., Jacobs D.R., et al. Plasma aldosterone levels and development of insulin resistance: prospective study in a general population. Hypertension 2011, 58:1043-1048.
20. Ogata K., Miyamoto T., Adachi H., et al. New computer model for prediction of individual 10-year mortality on the basis of conventional atherosclerotic risk factors. Atherosclerosis 2013, 227:159-164.
21. Yokoi K., Adachi H., Hirai Y., et al. Plasma endothelin-1 level is a predictor of 10-year mortality in a general population: the Tanushimaru study. Circ. J. 2012, 76:2779-2784.
22. Yoshikawa K., Adachi H., Hirai Y., et al. High serum N-acetyl-ß-d-glucosaminidase activity is a predictor of 28-year mortality in a population of community-dwelling Japanese-the Tanushimaru study. J.Am. Geriatr. Soc. 2013, 61:467-468.
23. Hino A., Adachi H., Toyomasu K., et al. Very long chain N-3 fatty acids intake and carotid atherosclerosis: an epidemiological study evaluated by ultrasonography. Atherosclerosis 2004, 176:145-149.
24. Kitagawa Y., Abe S., Toyoda S., et al. Gender differences in the ratio of eicosapentaenoic acid to arachidonic acid in an inland prefecture, Tochigi: Tochigi Ryomo EPA/AA Trial in Coronary Artery Disease (TREAT-CAD). Intern. Med. 2014, 53:177-182.
25. Childs C.E., Romeu-Nadal M., Burdge G.C., et al. Gender differences in the n-3 fatty acid content of tissues. Proc. Nutr. Soc. 2008, 67:19-27.
26. Malik A.R., Sultan S., Turner S.T., et al. Urinary albumin excretion is associated with impaired flow- and nitroglycerin-mediated brachial artery dilatation in hypertensive adults. J.Hum. Hypertens. 2007, 21:231-238.
27. Hermans M.M., Henry R., Dekker J.M., et al. Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the Hoorn Study. J.Am. Soc. Nephrol. 2007, 18:1942-1952.
28. Bonetti P.O., Lerman L.O., Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler. Thromb. Vasc. Biol. 2003, 23:168-175.
29. 14C]eicosapentaenoic acid by human platelets. Thromb. Res. 1982, 28:285-298.
30. Hamazaki T., Hirai A., Terano T., et al. Effects of orally administered ethyl ester of eicosapentaenoic acid (EPA; C20:5, omega-3) on PGI2-like substance production by rat aorta. Prostaglandins 1982, 23:557-567.
31. Terano T., Shiina T., Tamura Y. Eicosapentaenoic acid suppressed the proliferation of vascular smooth muscle cells through modulation of various steps of growth signals. Lipids 1996, (31 Suppl.l):S301-S304.
32. Möllsten A.V., Dahlquist G.G., Stattin E.L., et al. Higher intakes of fish protein are related to a lower risk of microalbuminuria in young Swedish type 1 diabetic patients. Diabetes Care 2001, 24:805-810.
33. Garman J.H., Mulroney S., Manigrasso M., et al. Omega-3 fatty acid rich diet prevents diabetic renal disease. Am. J. Physiol. Ren. Physiol. 2009, 296:F306-F316.
34. Hamazaki T., Takazakura E., Osawa K., et al. Reduction in microalbuminuria in diabetics by eicosapentaenoic acid ethyl ester. Lipids 1990, 25:541-545.
35. Lauretani F., Semba R.D., Bandinelli S., et al. Plasma polyunsaturated fatty acids and the decline of renal function. Clin. Chem. 2008, 54:475-481.
36. Bouwens M., van de Rest O., Dellschaft N., et al. Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells. Am. J. Clin. Nutr. 2009, 90:415-424.
37. Zhao H., Anand A.R., Ganju R.K. Slit2-Robo4 pathway modulates lipopolysaccharide-induced endothelial inflammation and its expression is dysregulated during endotoxemia. J.Immunol. 2014, 192:385-393.
38. De Caterina R., Madonna R., Bertolotto A., et al. n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data. Diabetes Care 2007, 30:1012-1026.
39. Domei T., Yokoi H., Kuramitsu S., et al. Ratio of serum n-3 to n-6 polyunsaturated fatty acids and the incidence of major adverse cardiac events in patients undergoing percutaneous coronary intervention. Circ. J. 2012, 76:423-429.
40. Nishizaki Y., Shimada K., Tani S., et al. Significance of imbalance in the ratio of serum n-3 to n-6 polyunsaturated fatty acids in patients with acute coronary syndrome. Am. J. Cardiol. 2014, 113:441-445.
41. Burdge G.C., Calder P.C. Dietary alpha-linolenic acid and health-related outcomes: a metabolic perspective. Nutr. Res. Rev. 2006, 19:26-52.
42. Arterburn L.M., Hall E.B., Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutr. 2006, 83:1467S-1476S.